HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Rinaldetti Selected Research

BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)

11/2017Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.
5/2015Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Rinaldetti Research Topics

Disease

2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2017 - 05/2015

Drug/Important Bio-Agent (IBA)

1Imatinib Mesylate (Gleevec)FDA Link
11/2017
1Cytarabine (Cytosar-U)FDA LinkGeneric
11/2017
1InterferonsIBA
11/2017
1Tyrosine Kinase InhibitorsIBA
05/2015